Correlation Between Defence Therapeutics and Vg Life

Can any of the company-specific risk be diversified away by investing in both Defence Therapeutics and Vg Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Defence Therapeutics and Vg Life into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Defence Therapeutics and Vg Life Sciences, you can compare the effects of market volatilities on Defence Therapeutics and Vg Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Defence Therapeutics with a short position of Vg Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Defence Therapeutics and Vg Life.

Diversification Opportunities for Defence Therapeutics and Vg Life

0.02

Correlation Coefficient

Defence Therapeutics  Vg Life

Significant diversification

The 3 months correlation between Defence and VGLS is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Defence Therapeutics and Vg Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vg Life Sciences and Defence Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Defence Therapeutics are associated (or correlated) with Vg Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vg Life Sciences has no effect on the direction of Defence Therapeutics i.e., Defence Therapeutics and Vg Life go up and down completely randomly.

Pair Corralation between Defence Therapeutics and Vg Life

Assuming the 90 days horizon Defence Therapeutics is expected to under-perform the Vg Life. But the otc stock apears to be less risky and, when comparing its historical volatility, Defence Therapeutics is 83.57 times less risky than Vg Life. The otc stock trades about -0.15 of its potential returns per unit of risk. The Vg Life Sciences is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Vg Life Sciences on May 8, 2025 and sell it today you would earn a total of  0.00  from holding Vg Life Sciences or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Defence Therapeutics  vs.  Vg Life Sciences

Defence Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Defence Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in September 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Vg Life Sciences

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Vg Life Sciences are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile essential indicators, Vg Life unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Defence Therapeutics and Vg Life

The main advantage of trading using opposite Defence Therapeutics and Vg Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Defence Therapeutics position performs unexpectedly, Vg Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vg Life will offset losses from the drop in Vg Life's long position.

The idea behind Defence Therapeutics and Vg Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.